Corporate News 27-Jan-23
Gland Pharma's Visakhapatnam facility concludes USFDA inspection
Gland Pharma announced that the United States Food and Drug Administration (US FDA) conducted an inspection at the Company's API Facility at JNPC, Visakhapatnam from 23 January 2023 to 27 January 2023 and has been completed with Zero observations.
Previous News
Gland Pharma consolidated net profit declines 20.14% in the September 2022 quarter
( Results - Announcements 27-Oct-22 08:12 )
Gland Pharma Ltd spurts 2.01%, gains for third straight session
( Hot Pursuit - 27-Dec-23 13:05 )
Volumes jump at Gland Pharma Ltd counter
( Hot Pursuit - 23-May-24 11:00 )
Gland Pharma Ltd soars 0.73%, up for fifth straight session
( Hot Pursuit - 16-May-24 13:00 )
Gland Pharma Ltd soars 0.86%, gains for fifth straight session
( Hot Pursuit - 09-Jun-23 13:00 )
Board of Gland Pharma appoints Chief Operating Officer
( Corporate News - 07-Aug-23 17:15 )
Board of Gland Pharma recommends final dividend
( Corporate News - 23-May-24 09:38 )
Gland Pharma
( Results - Analysis 07-Nov-23 10:30 )
Volumes spurt at Computer Age Management Services Ltd counter
( Hot Pursuit - 19-Aug-22 11:00 )
Gland Pharma Ltd down for fifth straight session
( Hot Pursuit - 20-Sep-22 13:35 )
Gland Pharma to conduct AGM
( Corporate News - 18-May-21 12:01 )
Other Stories
Board of Delhivery approves alteration in capital clause of MoA
05-Jul-24 19:32
J B Chemicals & Pharmaceuticals appoints director
05-Jul-24 19:30
Infosys announces resignation of senior management personnel
05-Jul-24 19:22
JLR Q1 FY25 retail sales up 9% on YoY basis
05-Jul-24 19:08
Bajaj Auto launches world's first CNG motorcycle 'Freedom'
05-Jul-24 18:59
Agenda for board meeting of Power Grid Corporation of India
05-Jul-24 18:46
Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
05-Jul-24 18:06
Vipul to hold board meeting
05-Jul-24 17:15
Markobenz Ventures to convene board meeting
05-Jul-24 17:15
Dhanashree Electronics to declare Quarterly Result
05-Jul-24 17:15
Back
Top
